FPFelipe Dinau Leal Passos

Felipe Dinau Leal Passos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Felipe Dinau Leal Passos has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Análise de colpocitologia oncológica em meio líquido e rastreio de infecções sexualmente transmissíveis por biologia molecular em mulheres em situação de vulnerabilidade social, na cidade do Rio de Janeiro

    by Mauro Romero Leal Passos, Sílvio Silva Fernandes, Waldyr Gomes da Costa, Michelle Gomes Soares Toledo, Christina Thereza Machado Bittar, Maurício de Souza Leão, Felipe Dinau Leal Passos, Gabriel Varella Leal Passos

    Introduction: Health interventions should be implemented at different levels of care for each population. Women with vulnerabilities are more susceptible to STIs, and most are asymptomatic. When symptomatic, they face difficulties in accessing care. Objective: To investigate pathogens of sexually transmitted infections using RT-PCR panel and liquid-based oncological colpocytology analysis in women in situations of social vulnerability in the city of Rio de Janeiro. Methods: Observational cross-sectional study for clinical and laboratory gynecological evaluation with collection of cervicovaginal samples among women in situations of social vulnerability, conducted from 2022–2023 in the Menina, Moça, Mulher project in the city of Rio de Janeiro. The analysis consisted of collecting samples for colposcopy (Bethesda 2018) in liquid medium (SurePath®) and RT-PCR Allplex™ STI, using Seegene MuDT™ technology (Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), and Trichomonas vaginalis (TV)). Serological tests for syphilis and HIV were performed. All tests were performed at the same registered laboratory. Exclusion criteria: systemic or vaginal treatment with antimicrobials within the last 30 days of the consultation. Results: 115 women were included. Twelve women were excluded for not meeting the requirements. The average age was 36 years. The youngest was 17 years old, the oldest 71 years old. Colposcopy results: Normal, 17 (14.78%), Mild inflammatory, 56 (48.59%), Moderate inflammatory, 26 (22.60%), Severe inflammatory, 1 (0.86%), Low-grade intraepithelial lesion, 6 (5.21%), Intraepithelial lesion of undetermined significance, 4 (3.47%), Atypical glandular cells, 1 (0.86%), Squamous cell carcinoma of the cervix, 2 (1.73%), confirmed by colposcopy and biopsy. The diagnosis of endometrial carcinoma, 1 (0.86%), was by endometrial biopsy with normal colpocitology, but presented clinical symptomatology, Unsatisfactory material, 1 (0.86%), Bacterial vaginosis, 6 (5.21%), Candidiasis, 7 (6.08%), Trichomoniasis, 3 (2.60%). RT-PCR results: TV, 15 (13.04%), CT, 5 (4.34%), NG, 2 (1.73%), MG, 1 (0.86%), MH, 31 (26.95%), UU, 20 (17.39%), UP, 37 (32.17%), Negative, 45 (39.13%). Several samples presented more than one pathogen. Diagnosis by TV colpocitology was 3 (2.60%) and by PCR was 15 (13.04%). Four women (4/115=3.47%) were positive for syphilis by treponemal and non-treponemal serology. Three other women (3/115=2.60%) were positive for HIV. Conclusion: The rates of STIs, alterations in oncotic colpocitology, including malignant lesions, and co-infections between STIs, HIV, and syphilis in vulnerable women in Rio de Janeiro are concerning. Diagnosis by PCR Testing for Trichomonas vaginalis was much more efficient than using colposcopy. People in situations of social vulnerability should have an open channel for medical care, STI screening, and gynecological examinations with laboratory resources.

  • Open Access

    A sad portrait of congenital syphilis in the State of Rio de Janeiro. Case report with Polymerase Chain Reaction (PCR) of scrapings from skin lesions and placenta fragment positive for Treponema pallidum

    by Felipe Dinau Leal Passos, Anderlúcia Corrêa Guedes, Ariela Gomes de Melo, Renata de Queiroz Varella, Isabelle de Carvalho Rangel, Ricardo de Souza Carvalho, Fernando Raphael de Almeida Ferry, Julia Sampaio de Souza Morais, Carolina Varella Leal Passos, Paula Varella Leal Passos, et al.

    Introduction: Congenital syphilis is a serious public health problem that causes high rates of intrauterine morbidity and mortality, revealing flaws and weaknesses in the health system. Objective: to report a case of congenital syphilis in a university hospital in the Center-South Region of the State of Rio de Janeiro, Brazil. Case report: A pregnant woman, aged between 19 and 23 years old, carrying a Pregnant Woman’s Handbook with a record of seven prenatal consultations and a note of the serological reaction for positive syphilis, but without any treatment, hospitalized at the University Hospital of Vassouras (RJ), in labor, gave birth to a newborn (NB) with a clinical picture and serological test of congenital syphilis. The NB required care in an intensive care unit and was discharged 28 days after birth. Scraping of skin lesions of the NB and placenta was performed for analysis by molecular biology (PCR in house) and genetic material of Treponema pallidum was detected. Conclusion: Congenital syphilis is a serious outcome of syphilis during pregnancy, consuming high financial resources and significant emotional distress for the mother, father, the whole family, as well as for the health teams. Our case report was the first that we are aware of in Brazil with a diagnosis by PCR for positive Treponema pallidum of skin scraping and placental fragment. It also showed poor quality prenatal care, a common factor in most cases of CS in our reality.

  • Open Access

    Serological ineptitude in blood banks: is there an association with sexually transmitted infections?

    by Julia Sampaio de Souza, Lissa Leonor Chaves Carvalho, Carolina Varella Leal Passos, Paula Varella Leal Passos Passos, Felipe Dinau Leal Passos, Anderlúcia Corrêa Guedes

    Introduction: Sexually transmitted infections (STIs) are a serious public health problem, and some of these infections are also transmitted through blood transfusions. Objective: To identify publications in scientific journals in Brazil and in the world showing if there is an important association between serological inadequacy due to sexually transmitted infections traced in blood and blood products used for medical use. Methods: Systematic review of articles published from 2018 to 2023, using the LILACS, SciELO and PubMed databases, with a concomitant approach to the issues of serological disability and STI. Original studies or review articles in Portuguese, English and Spanish with Brazilian and international data were included. Editorial publications, letter to the editor, letter from the editor or comments on the subject were excluded. Results: The search found 571 articles, of which 106 (18.40%) met the inclusion criteria, that is, Serological disability and STI. In studies with international data, the prevalence of donors with hepatitis C ranged from 0.12 to 4.8%; with hepatitis B, from 1.3 to 8.2%; with HIV, from 0.0021 to 2.5%; with syphilis, from 1.73 to 2.4%; with HTLV, 0.66%; and with Chagas disease, from 0.017 to 2.76%. Among articles with Brazilian data, the prevalence of donors with seroreactive tests for hepatitis C ranged from 0.18 to 1.76%; with hepatitis B, from 0.05 to 7.9%; with HIV, from 0.03 to 0.82%; with syphilis, from 0.37 to 3.51%; with HTLV, from 0.02 to 0.3%, and with Chagas disease, from 0.8 to 0.5%. Conclusion: STIs are rarely discussed in the scientific literature in studies on serological inadequacy. In addition, a minority of articles were with Brazilian data. However, results show that STIs, despite being little discussed in the scientific literature in studies on the subject of serological inadequacy, have statistically significant percentages of seropositivity for STIs. Moreover, hepatitis C and B have a relevant seroprevalence, reaching 8.2% and 4.8%, respectively, in the international scenario. In Brazil, hepatitis B continues to occupy a prominent place with a seroprevalence of up to 7.9%. However, syphilis now holds a very important role, with a maximum percentage of 3.51%. More studies are needed for further reflection: although STIs are little addressed in studies about serological inadequacy in human blood banks, would they contribute to the maintenance and non-reduction of the general frequency of infections transmitted by blood transfusion?